Background: The pathogenesis of breast cancer remains unclear. Aims: To investigate the pathogenesis of breast cancer through targeted metabolomics of amino acids components in serum of patients with breast cancer. Methods: Patients with breast cancers were enrolled in our hospital between year January 1
Introduction
Breast cancer, developing from breast tissue, remains the top reason for death of women. Unclear target information leads to the limited therapeutic drugs. Therefore, more and more studies are carried out to find new therapeutic targets. The long noncoding RNA SPRY4-IT1 has been demonstrated to be a novel prognostic biomarker and a potential therapeutic candidate for breast cancer 1 . The experiment performed by Finlay et al. showed that RNA-based TWIST1 inhibition can reduce breast cancer metastasis through dendrimer complex 2 . However, all these reasons can not completely ex-plain the pathogenesis of breast cancer. The elucidation of a new mechanism for breast cancer pathogenesis is important and necessary.
Metabolomics analysis is an art-of-work technology for profiling all the small molecules in the biosamples (e.g., urine, serum, etc.). Metabolomics has been successfully applied to explain the pathogenesis of diseases, and the efficiency, pharmacokinetic behavior, and toxicity of xenobiotics 3 . Metabolomics studies indicated the importance of intestinal farnesoid X receptor signaling in the pathogenesis of nonalcoholic fatty liver disease 4 . The experiment performed by Zhang et al. showed that persistent organic pollutants can modify gut microbiota-host metabolic homeostasis in mice through aryl hydrocarbon receptor activation
5
. The present study aims to compare the metabolomics profile of serum between health volunteers and patients withbreast cancer to find the key inducing factor for breast cancer.
Materials and methods

Patients and biosamples preparation
Healthy volunteers (n=50, age, 18-70 years; body weight, 45-90kg) and patients with breast cancers (n=20, age, 18-68 years; body weight, 40-85kg) were enrolled in our hospital between year January 1 st , 2013 and December 31 st , 2014. The patients were confirmed using histological and cytological examination methods. The patients with a second primary malignancy, distant metastasis, or any serious concomitant systemic disorders were excluded from this study. The blood samples were taken 3 months from the beginning, and stored at -80 o C.
Targeted analysis of amino acids components 10 uL of serum was added in the 190 uL 95% acetonitrile to deproteinization. After 20-min centrifugation at 14,000*g, the aliquots (10 uL) were dropped on the filter paper. The filter paper was put into a 96-well polypropylene micro titer plates. 100 µL of methanol solution containing isotope labeled amino acid and acylcarnitine internal standards (NSK-A, NSK-B, Cambridge Isotope Laboratories, Andover, USA). 30 min gentle shaking at room temperature was performed. 60 µL of 3n butanolic-HCL was added for derivatisation at 65°C after evaporation at 70°C for 50 min. Determination of tryptophan-induced IL-10 secretion CD4+CD25-T cells for cell culture were separated by EasySep™ Mouse CD4+CD25+ Regulatory T Cell Isolation Kit were from Stemcell Technologies, and were cultured with plated bound anti-CD3 (5 μg/ml) and soluble anti-CD28 (2 μg/ml) antibodies in the presence or absence of tryptophan for 24 hours. After that, cells were collected for IL-10 mRNA expression. IL-10 protein in culture supernatants was determined by ELI-SA analysis.
Quantitative polymerase chain reaction (qPCR) analysis
A total of liver RNA was extracted using TRIzol reagent (Invitrogen, Carlsbad, CA), and cDNA was generated from 1 µg RNA with a SuperScript IITM Reverse Transcriptase kit and random oligonucleotides (Invitrogen, Grand Island, NY). The primer pairs were designed using qPrimerDepot, and messenger RNA quantitation was performed using the comparative cycle threshold (CT) method. The expression of mRNA was normalized to mouse 18S rRNA.
Results
Targeted metabolomics of amino acids showed that the level of tryptophan significantly (p<0.05) increased in patients with breast cancer (Figure 1) . The blood sample was taken 3 months since the beginning of the experiment.
Furthermore, the biological function of tryptophan was determined through determining the influence of tryptophan towards IL-10 secretion using in vitro method. The addition of tryptophan (100 uM) in the cell medium can significantly inhibited the secretion of IL-10 by CD4+ T cells, as indicated by the mRNA level ( Figure  2A ) and protein concentration ( Figure 2B ). 
Discussion
Interleukin-10 (IL-10) is a multifunctional cytokine which exerts the ability to inhibit the activation and effector function of T cells. Generally speaking, the function of IL-10 is to limit and even terminate the immune reaction 6 . The relationship between IL-10 and pathogenesis of cancers has been reported in previous literature. For example, the experiment performed by Chard et al. has shown that a vaccinia virus armed with IL-10 is a promising therapeutic agent for pancreatic cancer The present study used metabolomics method to find the significant elevation of tryptophan in serum, and no change for other amino acids. In vitro experiment showed the inhibition of tryptophan towards the IL-10 by T cells, indicating that inhibition of IL-10 secretion by elevated tryptophan was a potential pathogenesis of breast cancer. This phenomenon has been previously reported in previous literature 9 .
Conclusion
The present study gives a short communication on the pathogenesis of breast cancer, which will be beneficial for the understanding of mechanism of breast cancer and the discovery of new drugs for breast cancer.
